โ† All CCA Flashcard Decks

CATO Associate Site Initiation & Management Flashcards

6 cards from real CCA practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 6 CATO Associate Site Initiation & Management flashcards as text
  1. What document formally authorizes a clinical site to begin enrolling subjects in a trial?

    Answer: IRB/IEC Approval

    IRB/IEC approval is the formal authorization that permits a site to begin enrolling subjects into a clinical trial.

  2. During a site initiation visit (SIV), what is the primary purpose of reviewing the delegation log?

    Answer: To confirm staff qualifications and assigned responsibilities

    The delegation log is reviewed at SIV to confirm that all site staff are properly qualified and have been assigned appropriate trial responsibilities.

  3. Which regulatory document must be in place at the site BEFORE any subject can sign the informed consent form?

    Answer: IRB/IEC approval of the consent form

    IRB/IEC approval of the informed consent form must be obtained before any subject is consented.

  4. What is the term for the organized set of essential documents that must be maintained at the investigative site throughout a clinical trial?

    Answer: Investigator Site File (ISF)

    The Investigator Site File (ISF) contains the essential documents required at the site to demonstrate compliance with GCP and regulatory requirements.

  5. When a new sub-investigator joins the study team, what is the first required action by the principal investigator?

    Answer: Update the delegation log and submit CV to sponsor

    The PI must update the delegation log with the sub-investigator's roles and submit their CV and training records to the sponsor.

  6. Which activity is performed during a site qualification visit (SQV)?

    Answer: Evaluating the site's capability and resources to conduct the trial

    The SQV assesses whether a site has the necessary facilities, staff, and patient population to conduct the trial before selection.